Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
43,565,035
-
Share change
-
-3,078,543
-
Total reported value
-
$3,769,709,914
-
Put/Call ratio
-
196%
-
Price per share
-
$86.57
-
Number of holders
-
348
-
Value change
-
-$257,689,571
-
Number of buys
-
189
-
Number of sells
-
120
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q3 2017
As of 30 Sep 2017,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
348 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,565,035 shares.
The largest 10 holders included
MORGAN STANLEY, GOLDMAN SACHS GROUP INC, CITIGROUP INC, BNP PARIBAS ARBITRAGE, SA, BANK OF AMERICA CORP /DE/, JPMORGAN CHASE & CO, UBS Group AG, WELLS FARGO & COMPANY/MN, CREDIT SUISSE AG/, and ASSETMARK, INC.
This page lists
350
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.